Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-20-064659)

Filing Details

Accession Number:
0001209191-20-064659
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-21 16:47:04
Reporting Period:
2020-12-17
Accepted Time:
2020-12-21 16:47:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1672619 Imara Inc. IMRA Pharmaceutical Preparations (2834) 811523849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1805097 D. Rahul Ballal C/O Imara Inc.
116 Huntington Avenue, 6Th Floor
Boston MA 02116		 Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-17 4,999 $3.15 4,999 No 4 M Direct
Common Stock Disposition 2020-12-17 4,999 $25.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-12-17 4,999 $0.00 4,999 $3.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
263,999 2028-10-18 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Dr. Ballal's trading plan under Rule 10b5-1.
  2. The option was granted on October 19, 2018. The shares underlying the option vest over four years, with 25% of the shares vested on May 29, 2019 and the remaining shares vesting in equal quarterly installments thereafter.